Literature DB >> 8964422

Bilirubin cycles enterohepatically after ileal resection in the rat.

M A Brink1, N Méndez-Sánchez, M C Carey.   

Abstract

BACKGROUND & AIMS: Patients with ileal disease, resection, or bypass are at increased risk of developing pigment gallstones, but the pathophysiological mechanisms are unknown. The aim of this study was to test the hypothesis that ileectomy induces enterohepatic cycling of bilirubin.
METHODS: Ileectomy or sham operation was performed in adult male Sprague-Dawley rats with the following control procedures: no operation, ileal transection, proximal or distal jejunectomy, ileocolonic transposition, and ileocecectomy. Bilirubin and bile salt secretion rates were measured after bile duct cannulation performed 3-11 days after intestinal surgery. Also measured were bilirubin and bile salt concentrations in the colon as well as indices of hemolysis in blood.
RESULTS: Compared with controls, bilirubin secretion rates were increased significantly 3-5 days after ileectomy, distal jejunectomy, ileocolonic transposition, and ileocecectomy, with no hemolysis occurring. Bile salt secretion rates also increased significantly after ileectomy but decreased markedly with prevention of coprophagy, whereas bilirubin secretion rates remained elevated. By 8-11 days after surgery, intestinal adaptation normalized bile salt reabsorption, and hypersecretion of bilirubin was abolished. Colonic levels of unconjugated bilirubin and bile salts were increased fivefold and eightfold respectively in ileectomized animals, but unconjugated bilirubin levels remained normal in bile.
CONCLUSIONS: These results are consistent with the hypothesis that enterohepatic cycling of bilirubin occurs with bile salt malabsorption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964422     DOI: 10.1053/gast.1996.v110.pm8964422

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

Authors:  Evita van de Steeg; Els Wagenaar; Cornelia M M van der Kruijssen; Johanna E C Burggraaff; Dirk R de Waart; Ronald P J Oude Elferink; Kathryn E Kenworthy; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Localization of the ileal sodium-bile salt cotransporter gene (Slc10a2) to mouse chromosome 8.

Authors:  F Lammert; B Paigen; M C Carey
Journal:  Mamm Genome       Date:  1998-02       Impact factor: 2.957

3.  Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.

Authors:  Folke Freudenberg; Monika R Leonard; Shou-An Liu; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

Review 4.  New pathophysiological concepts underlying pathogenesis of pigment gallstones.

Authors:  Libor Vítek; Martin C Carey
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-10-05       Impact factor: 2.947

Review 5.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor.

Authors:  Darcey L H Smith; Pavitra Keshavan; Uri Avissar; Kashif Ahmed; Stephen D Zucker
Journal:  Carcinogenesis       Date:  2010-03-01       Impact factor: 4.944

7.  Gallbladder bile composition in patients with Crohn 's disease.

Authors:  Annika Lapidus; Jan-Erik Akerlund; Curt Einarsson
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

8.  Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model.

Authors:  Folke Freudenberg; Annemarie L Broderick; Bian B Yu; Monika R Leonard; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

9.  Unconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption.

Authors:  Chong Zhao; Hongli Huang; Qiuhua Pan; Wenqi Huang; Wu Peng; Haoming Xu; Zhiqiang Feng; Yanlei Du; Yuqiang Nie; Yongjian Zhou
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

Review 10.  Liver disease secondary to intestinal failure.

Authors:  Bassam Abu-Wasel; Michele Molinari
Journal:  Biomed Res Int       Date:  2014-01-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.